Paclitaxel-loaded iron platinum stealth immunomicelles are potent MRI imaging agents that prevent prostate cancer growth in a PSMA-dependent manner
Robert M Taylor,1,2 Laurel O Sillerud1,31Department of Biochemistry and Molecular Biology, 2New Mexico Cancer Nanoscience and Microsystems Training Center, 3UNM Cancer Center, University of New Mexico, Albuquerque, NM, USABackground and methods: Problems with the clinical management of prostate canc...
Main Authors: | Taylor RM, Sillerud LO |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-08-01
|
Series: | International Journal of Nanomedicine |
Online Access: | http://www.dovepress.com/paclitaxel-loaded-iron-platinum-stealth-immunomicelles-are-potent-mri--a10620 |
Similar Items
-
Quantitative [Fe]MRI of PSMA-targeted SPIONs specifically discriminates among prostate tumor cell types based on their PSMA expression levels
by: Sillerud LO
Published: (2016-01-01) -
‘Stealth’ Prostate Tumors
by: Vinayak G. Wagaskar, et al.
Published: (2023-07-01) -
Efficient, chemoselective synthesis of immunomicelles using single-domain antibodies with a C-terminal thioester
by: Raats Jos MH, et al.
Published: (2009-07-01) -
Prostate MRI and PSMA-PET in the Primary Diagnosis of Prostate Cancer
by: Lorenzo Cereser, et al.
Published: (2023-08-01) -
Clinical perspectives of PSMA PET/MRI for prostate cancer
by: Felipe de Galiza Barbosa, et al.
Published: (2018-09-01)